Abstract:Catastrophizing, a persistent negative mental set characterized by helplessness, rumination, and magnification of pain sensations, has a potent effect on pain report and clinical outcomes. Previous studies have documented an association between cognitive factors and central sensitization.The current analysis sought to test the potential modulating effect of pain catastrophizing on the association between capsaicin pain and the region of secondary hyperalgesia. Thirty-eight healthy individuals (50% women, mean … Show more
“…43 In an experimental pain setting, Pressman and co-workers found that in healthy individuals, relatively low levels of catastrophising (PCS 10.6) moderated the association between pain and such secondary hyperalgesia. 44 Therefore, in samples with similar subclinical levels of pain catastrophising such as ours, mild catastrophic thinking may be an early predictor of pain chronification, a notion that warrants further research.…”
Section: Discussionmentioning
confidence: 67%
“…The pain attention behaviour embedded in catastrophic thinking could, however, be a significant mediator in the transition from acute to chronic pain condition; a hyperalgesic state often associated with widespread pain 43 . In an experimental pain setting, Pressman and co‐workers found that in healthy individuals, relatively low levels of catastrophising (PCS 10.6) moderated the association between pain and such secondary hyperalgesia 44 …”
Aims
Temporomandibular disorders (TMD) are often associated with psychological comorbidities. One such comorbidity is pain catastrophising, that is, exaggeration of negative consequences of a painful event. The aim was to investigate catastrophising in individuals with painful TMD compared to controls and the association between catastrophising and pain intensity, number of pain sites and functional limitations.
Methods
A community‐based sample of 110 individuals (83 women; 20–69 yrs) with painful TMDs (myalgia/arthralgia as per Diagnostic Criteria for TMD) and 190 age‐ and gender‐matched controls (119 women; 20–69 yrs) from the Public Dental services in Västerbotten, Sweden, participated. Associations between catastrophising and functional jaw limitations, respectively, and painful TMD were evaluated with ordinal regression adjusted for the effect of gender and age. Associations (Spearman's correlation) of the Pain catastrophising Scale (PCS) with Jaw Functional Limitation Scale (JFLS‐20), pain site number (whole‐body pain map), and characteristic pain intensity (CPI) and intergroup comparisons (Mann‐Whitney U test) of these variables were also calculated.
Results
Levels of catastrophising were associated with TMD pain (OR 1.6, 95%CI 1.1–2.6). Among individuals with painful TMD, catastrophising was correlated to pain intensity (r=0.458, p<0.01) and functional limitations (r=0.294–0.321, p≤0.002), but not to number of pain sites.
Conclusion
Compared to controls, community‐based individuals with painful TMD demonstrated higher levels of pain catastrophising, and this catastrophising was associated with increased pain intensity and jaw dysfunction. The relatively low scores of pain catastrophising suggest that even mild catastrophic thinking is associated with pain perception and jaw function, and should be considered in patient management.
“…43 In an experimental pain setting, Pressman and co-workers found that in healthy individuals, relatively low levels of catastrophising (PCS 10.6) moderated the association between pain and such secondary hyperalgesia. 44 Therefore, in samples with similar subclinical levels of pain catastrophising such as ours, mild catastrophic thinking may be an early predictor of pain chronification, a notion that warrants further research.…”
Section: Discussionmentioning
confidence: 67%
“…The pain attention behaviour embedded in catastrophic thinking could, however, be a significant mediator in the transition from acute to chronic pain condition; a hyperalgesic state often associated with widespread pain 43 . In an experimental pain setting, Pressman and co‐workers found that in healthy individuals, relatively low levels of catastrophising (PCS 10.6) moderated the association between pain and such secondary hyperalgesia 44 …”
Aims
Temporomandibular disorders (TMD) are often associated with psychological comorbidities. One such comorbidity is pain catastrophising, that is, exaggeration of negative consequences of a painful event. The aim was to investigate catastrophising in individuals with painful TMD compared to controls and the association between catastrophising and pain intensity, number of pain sites and functional limitations.
Methods
A community‐based sample of 110 individuals (83 women; 20–69 yrs) with painful TMDs (myalgia/arthralgia as per Diagnostic Criteria for TMD) and 190 age‐ and gender‐matched controls (119 women; 20–69 yrs) from the Public Dental services in Västerbotten, Sweden, participated. Associations between catastrophising and functional jaw limitations, respectively, and painful TMD were evaluated with ordinal regression adjusted for the effect of gender and age. Associations (Spearman's correlation) of the Pain catastrophising Scale (PCS) with Jaw Functional Limitation Scale (JFLS‐20), pain site number (whole‐body pain map), and characteristic pain intensity (CPI) and intergroup comparisons (Mann‐Whitney U test) of these variables were also calculated.
Results
Levels of catastrophising were associated with TMD pain (OR 1.6, 95%CI 1.1–2.6). Among individuals with painful TMD, catastrophising was correlated to pain intensity (r=0.458, p<0.01) and functional limitations (r=0.294–0.321, p≤0.002), but not to number of pain sites.
Conclusion
Compared to controls, community‐based individuals with painful TMD demonstrated higher levels of pain catastrophising, and this catastrophising was associated with increased pain intensity and jaw dysfunction. The relatively low scores of pain catastrophising suggest that even mild catastrophic thinking is associated with pain perception and jaw function, and should be considered in patient management.
Background and ObjectiveThe relationship between chronic daily headache (CDH), depression symptoms, and brain volume remains unclear.MethodsTo investigate the effects of CDH on brain volume and the impact of depressive symptoms (DSs) as well as the effects of demography and medication overuse, PubMed, Embase, and Web of Science databases were systematically searched using appropriate keyword strings to retrieve observational studies from inception to May 2023.ResultsTwo distinct comparisons were made in CDH patients: (1) those with DSs versus their pain‐free counterparts and (2) those without DSs versus pain‐free controls. The first comprised nine studies enrolling 225 CDH patients with DSs and 234 controls. Beck depression inventory, Hamilton depression scale, and Hospital anxiety/depression scale were used to assess DSs, revealing significantly more DSs in CDH patients with DSs compared to their controls (all p < 0.05). Besides, the second analysed four studies involving 117 CDH patients without DSs and 155 comparators. Compared to CDH patients without DSs, those with DSs had a smaller brain volume than controls (p = 0.03). Furthermore, CDH patients with DSs who did not overuse medications showed a smaller right cerebral cortical volume than overusers (p = 0.003). A significant inverse correlation between female prevalence and brain volume (p = 0.02) was revealed using regression analysis.ConclusionsPain‐induced persistent depressive symptoms not only incur structural alterations but also encompass affective‐motivational changes, involving medication use and gender‐specific health concerns.SignificanceThis study highlighted the importance of an integrated CDH treatment, emphasizing psychological interventions for the affective‐motivational component alongside pain management.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.